#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare
Peter Attia, MD, explores how obscure basic science discoveries have led to major medical breakthroughs. He traces the fascinating stories behind GFP, statins, ACE inhibitors, PCR, CRISPR, and GLP-1 agonists, making a case for investing in curiosity-driven research as essential for future medical innovation.
Deep Dive Analysis
11 Topic Outline
Introduction: The Value of Basic Science in Medical Progress
The Discovery and Impact of Green Fluorescent Protein (GFP)
Nature's Toolkit: Evolution as a Source of Medical Solutions
The Discovery of Statins from Fungi
The Discovery of ACE Inhibitors from Snake Venom
The Discovery of PCR from Yellowstone Hot Springs Microbe
The Discovery of CRISPR from Salt Pond Archaea
The Discovery of GLP-1 Receptor Agonists from Gila Monster Venom
Recap: The Unpredictable Path of Medical Innovation
The Importance of Funding Curiosity-Driven Basic Research
Biomedical Science as a Continuum
8 Key Concepts
Green Fluorescent Protein (GFP)
A protein isolated from jellyfish that emits green light when exposed to blue light. It's revolutionary because it folds itself, builds its own fluorescent core, and works in almost any cell or organism, allowing scientists to visualize biological processes in real-time.
HMG-CoA Reductase
A key enzyme in the body responsible for the rate-limiting step in cholesterol synthesis. Inhibiting this enzyme was understood to be a way to lower cholesterol levels, leading to the search for statins.
Bradykinin
A potent vasodilator peptide discovered from Brazilian pit viper venom. It is a fundamental player in mammalian cardiovascular biology, regulating blood pressure, vascular permeability, and inflammation.
Angiotensin Converting Enzyme (ACE)
An enzyme that converts angiotensin 1 to angiotensin 2 (a vasoconstrictor) and also degrades bradykinin (a vasodilator). Inhibiting ACE became a target for drugs to lower blood pressure.
Polymerase Chain Reaction (PCR)
A technique that allows scientists to make billions of copies of a specific DNA sequence in a test tube. It revolutionized molecular biology by enabling the amplification of DNA for genetic testing, forensic analysis, and gene therapy development.
Thermus aquaticus (Taq Polymerase)
A species of thermophilic bacteria discovered in Yellowstone hot springs that can thrive in extreme heat. Its DNA polymerase (Taq polymerase) is stable at high temperatures, making PCR practical by eliminating the need to add fresh enzyme in each cycle.
CRISPR
(Clustered Regularly Interspaced Short Palindromic Repeats) An adaptive immune system found in bacteria and archaea that stores snippets of viral DNA (spacers) to recognize and destroy future viral infections. This system was later engineered into a powerful gene-editing tool.
GLP-1 Receptor Agonists
A class of drugs that activate the glucagon-like peptide 1 (GLP-1) receptor, stimulating insulin secretion, suppressing appetite, and slowing gastric emptying. The first in this class, Exenatide, was derived from a peptide found in Gila monster venom.
8 Questions Answered
Many foundational medical advances, like GFP, statins, ACE inhibitors, PCR, CRISPR, and GLP-1 agonists, originated from scientists studying natural phenomena without an immediate clinical goal, driven purely by curiosity about how nature works.
GFP was discovered by Osamu Shimamuru while studying how the Aequorea victoria jellyfish produces light, leading him to isolate two proteins, aquarin and GFP, the latter of which became a revolutionary tool for visualizing biology in living cells.
Statins originated from Akiro Endo's search for natural inhibitors of HMG-CoA reductase, leading him to discover a compound produced by Penicillium citronum fungus, which had evolved a chemical weapon to inhibit bacterial sterol synthesis.
ACE inhibitors trace back to the study of Brazilian pit viper venom, which causes a sudden drop in blood pressure, leading to the discovery of Bradykinin and later the identification of Angiotensin Converting Enzyme (ACE) and its inhibitors.
PCR was made practical by the discovery of Taq polymerase from Thermus aquaticus, a microbe found in Yellowstone hot springs by Thomas Brock, who was studying organisms that live in extreme temperatures.
CRISPR was discovered by Francisco Mojica, who was studying the genome of a salt-loving archaea and noticed strange repeating sequences that turned out to be a record of past viral infections, functioning as an adaptive immune system.
GLP-1 receptor agonists were discovered by John Eng, who investigated why Gila monster venom caused pancreatic inflammation, leading him to isolate Exendin-4, a peptide similar to human GLP-1 but with a much longer half-life.
Investing in curiosity-driven basic research is essential because we are 'demonstrably terrible' at predicting which projects will lead to transformative medical innovations, and many critical therapies have emerged from such seemingly irrelevant inquiries.
3 Actionable Insights
1. Prioritize Curiosity-Driven Research
Fund basic scientific research that explores fundamental questions about nature, even if its immediate clinical application is not obvious, as these often lay the groundwork for transformative medical breakthroughs.
2. Rethink Research Evaluation Criteria
Avoid solely judging research proposals based on their near-term translational impact or direct proximity to curing a disease, as this filter can overlook foundational discoveries.
3. Leverage Nature’s Solutions for Medicine
When seeking solutions to medical problems, recognize that evolution has already developed a vast toolkit of molecules and mechanisms; sometimes the most productive approach is to find the organism that already invented it.
5 Key Quotes
He was a man with scissors, cutting rings off jellyfish, because he wanted to know how the animal glowed.
Peter Attia
Nature has been running experiments across millions of species for roughly 4 billion years... And while it hasn't solved our problems for us, it has often already created some of the components of the solutions we're looking for.
Peter Attia
If nature has already touched so many of these problems, then sometimes the most productive thing a scientist can do is not invent something new, it's to find the organism that already invented it.
Peter Attia
I want to study how a jellyfish glows is not a fundable proposal in that framework.
Peter Attia
We are demonstrably terrible at predicting which curiosity-driven work is going to matter.
Peter Attia